Announced Tue, 7 Jul · 11:24 IST
Routine demat compliance certificate for June 2026 quarter
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹39.89
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.7+1.5-2.2+5.3+5.3+1.1-1.3———
Up moveDown movePending
AI summary
Sudarshan Pharma has submitted to BSE the Regulation 74(5) certificates from its registrar KFin Technologies for the quarter ended 30 June 2026. The certificates, issued to CDSL and NSDL, confirm that details of shares dematerialized and rematerialized during the quarter were furnished to the stock exchanges. This is a standard periodic compliance filing required of every listed company, with no operational or financial numbers involved.
Likely market impact
Routine compliance filing, no impact on share price or business outlook.